An In Silico Approach towards the Prediction of Druglikeness Properties of Inhibitors of Plasminogen Activator Inhibitor1

Table 9

Bioactivity of the selected ligands of PAI1.

Ligand		Solubility	Molecular weight	Druglikeness	Drug score
2-Acetylamino-2-deoxy-A-D-glucopyranose	−1.63	−0.15	191.01	−0.50	0.67
Alpha-L-fucose	−1.63	−0.15	101.00	−0.56	0.67
Beta-D-mannose	−3.5	0.42	312.00	−5.08	0.38
N-Acetyl-D-glucosamine	−2.3	−0.02	221.00	−3.05	0.5
Ribose	−1.3	−0.06	134.00	−5.68	0.4